Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Accepts healthy volunteers

Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood

ClinicalTrials.gov ID: NCT02225041

Public ClinicalTrials.gov record NCT02225041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the relationships between sedative exposure during pediatric critical illness and long-term neurocognitive outcomes. We will test for drug- and dose-dependent relationships between sedative exposure and neurocognitive outcomes along the early developmental spectrum and will control for baseline and environmental factors, as well as the severity and course of illness. Hypotheses: 1. Greater exposure to benzodiazepines and/or ketamine will be associated with lower IQ even when controlling for severity of illness, hospital course, and baseline factors. In addition, benzodiazepines and/or ketamine will negatively affect other aspects of neurocognitive function. 2. Younger children exposed to benzodiazepines and/or ketamine will have worse neurocognitive outcomes than older children with similar sedative exposure and severity of illness.

Study identification

NCT ID
NCT02225041
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
University of Pennsylvania
Other
Enrollment
360 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Months to 13 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2014 (Actual)
Primary completion
Dec 2018 (Actual)
Completion
Dec 2018 (Actual)
Last update posted
Jun 18, 2019

2014 – 2018

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
University Medical Center, The University of Arizona Tucson Arizona 85724 —
Children's Hospital and Research Center at Oakland Oakland California 94609-1809 —
Children's Hospital of Orange County Orange California 92868 —
Lucile Salter Packard Children's Hospital at Stanford Palo Alto California 94304-0126 —
University of California Davis Medical Center Sacramento California 95817 —
Children's Hospital at University of California San Francisco Medical Center San Francisco California 94143 —
Connecticut Children's Medical Center Hartford Connecticut 06106 —
Yale-New Haven Children's Hospital New Haven Connecticut 06520-8064 —
Nemours/Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Holtz Children's Hospital Miami Florida 33136 —
Florida Hospital for Children Orlando Florida 32803 —
Children's Memorial Hospital, Chicago Chicago Illinois 60614-3363 —
Advocate Hope Children's Hospital Oak Lawn Illinois 60453 —
University of Maryland Hospital for Children Baltimore Maryland 21201-1595 —
Johns Hopkins Children's Center Baltimore Maryland 21287 —
University of Massachusetts Memorial Children's Medical Center Worcester Massachusetts 01655 —
C. S. Mott Children's Hospital of the University of Michigan Ann Arbor Michigan 48109-0243 —
Children's Mercy Hospital, Kansas City Kansas City Missouri 84108 —
St. Louis Children's Hospital St Louis Missouri 63110 —
University of Nebraska Medical Center Omaha Nebraska 68114 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756-0001 —
Cohen Children's Medical Center of New York New Hyde Park New York 11040 —
The Children's Hospital at Montefiore The Bronx New York 10467 —
Duke Children's Hospital and Health Center Durham North Carolina 27710 —
Doernbecher Children's Hospital Portland Oregon 97239 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
Monroe Carell, Jr. Children's Hospital at Vanderbilt Nashville Tennessee 37232-9075 —
Medical City Children's Hospital Dallas Texas 75230 —
Children's Medical Center Dallas Dallas Texas 75235 —
Primary Children's Medical Center Salt Lake City Utah 84113 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02225041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02225041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →